Zomedica Corp
General ticker "ZOM" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $132.3M (TTM average)
Zomedica Corp does not follow the US Stock Market performance with the rate: -9.9%.
Estimated limits based on current volatility of 11.8%: low 0.05$, high 0.06$
Factors to consider:
- US accounted for 82.7% of revenue in the fiscal year ended 2024-12-31
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.11$, 0.38$]
- 2024-12-30 to 2025-12-30 estimated range: [0.11$, 0.37$]
Financial Metrics affecting the ZOM estimates:
- Negative: Non-GAAP EPS, $ of -0.03 <= 0.04
- Negative: negative Net income
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.27 <= 1.81
- Negative: Industry operating cash flow per share per price (median), % of -6.18 <= 2.91
- Positive: Industry inventory ratio change (median), % of -0.15 <= 0
Short-term ZOM quotes
Long-term ZOM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $4.13MM | $18.93MM | $25.19MM |
| Operating Expenses | $25.51MM | $40.85MM | $68.46MM |
| Operating Income | $-21.37MM | $-21.92MM | $-43.27MM |
| Non-Operating Income | $0.66MM | $2.54MM | $7.42MM |
| Interest Expense | $0.01MM | $0.00MM | $0.17MM |
| R&D Expense | $1.67MM | $2.58MM | $5.74MM |
| Income(Loss) | $-20.72MM | $-19.38MM | $-35.86MM |
| Taxes | $-2.33MM | $-2.37MM | $-1.33MM |
| Profit(Loss)* | $-18.38MM | $-17.02MM | $-34.53MM |
| Stockholders Equity | $270.89MM | $267.39MM | $240.02MM |
| Inventory | $2.85MM | $2.75MM | $5.12MM |
| Assets | $280.40MM | $279.61MM | $253.20MM |
| Operating Cash Flow | $-14.28MM | $-11.67MM | $-15.97MM |
| Capital expenditure | $0.53MM | $1.03MM | $4.65MM |
| Investing Cash Flow | $-71.93MM | $-155.88MM | $1.58MM |
| Financing Cash Flow | $219.16MM | $0.01MM | $0.00MM |
| Earnings Per Share** | $-0.02 | $-0.02 | $-0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.